Focused tracks


CPhI Conferences is pleased to present the 4th edition of Biopharma Conclave scheduled on 15-16th September 2022 in Mumbai. This comprehensive 2-day conclave will have parallel sessions on Innovation & Novel Technology, Late Development, Regulatory & Operations and Commercialization & Marketing. This event will be a single platform for all Biopharma professionals to gain insights on Planning to Execution such as Research & Development (R&D), Manufacturing, Clinical Trials, Patent Framework, Commercialization and Marketing of the biopharma drugs. The objective of this conclave is to deliberate on crucial and the most relevant topics to enlighten the bio-pharma professionals in this domain. With case studies, innovation showcases and interactive panel discussions, utilize this exciting opportunity to meet and hear from the movers and shakers in the industry.


Innovation & Novel Technology This track focusses on emerging technologies & novel therapeutics for NBE, Biosimilars, Vaccines & Cell and Gene therapy
Late Development Focused on clinical Trials, Characterization in Novel Biologics, Biosimilar, Vaccines& Cell and Gene therapy
Regulatory & Operations Discusses on FDA, DCGI, and other regulatory bodies, Manufacturing, Supply Chain in Novel Biologics, Biosimilar, Vaccines & Cell and Gene therapy
Commercialization & Marketing The track discusses Affordability, Equal Availability, Pricing, M&A, Collaboration, Marketing of Novel Biologics, Biosimilar, Vaccines& Cell and Gene therapy

Speakers 2022


Biopharma Conclave as a platform is vital to bridge the pre-requisite and comprehensive knowledge. It was a great experience and I would like to visit this event again next year.

Prashant Kumar

Deputy General Manager, Bharat Serums & Vaccines Ltd.

Participants from major biopharma companies gathered here, many deals made and many thoughts changed which is just as important.

Dr. Sarfaraz K. Niazi

SI, FRSB, FPAMS, FACB,Founder, Karyo Biologics, Adello Biologics and PharmaSci, Adj Prof., University of Illinois and University of Houston

My overall experience at the conference was great; it was useful based on the knowledge shared by the speakers and product information shared by the exhibitors at the event.

Dr. Sumant S. Karnik

Head Quality Assurance, Haffkine Bio-Pharmaceutical

I would like to congratulate the team and organizer for grand success of your event. It was well designed and quality conference ever I have attended in India. Very beneficial to all Biopharma companies. The Speakers, Venue and Conference Design everything was excellent-Keep it up.

Sanjeev Gupta, Ph.D.

Sr. General Manager, Advanced Biotech Lab

The conference was very well organized, the speaker line up was good and balanced and the overall energy at the event was great!

Divya Bishnoi

Marketing Manager, Sartorius Stedim Biotech.


Informa AllSecure is our approach to enhanced health & safety standards at our events following COVID-19.

Informa has collaborated with association partners including UFI, AEO and SISO, peers including Reed Exhibitions and Clarion, venues, suppliers, contractors and health, government and local authorities to develop industry-wide AllSecure standards that raise the bar on safe, hygienic, productive and high-quality organised event experiences.

Informa AllSecure is how these standards are being adopted in our business. It means that when exhibitors, speakers, sponsors and attendees come to our events, they can connect, learn, know more and do more business, effectively, safely and with confidence.

 Download Health & Safety Guide    Find out more